The GLP is committed to full transparency. Download and review our 2019 Annual Report

Delayed by IARC designation, EPA glyphosate reassessment punted to next administration

| | September 15, 2016
Screen Shot at AM
Photo by Mike Mozart/Flickr
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

For anyone who thought EPA’s glyphosate risk assessment would arrive sometime soon, think again. The new target is for the draft assessment to arrive in the spring … as in, at the beginning of the next administration. …EPA is more than two years late in proposing risk levels that will serve as the basis for whether officials decide to keep the controversial herbicide on the market…

“Best-case scenario, you are looking at April 2017,” a former EPA official said of the timing for the draft risk assessment’s release. But, if the Senate or the next administration stalls in getting new EPA leadership approved, it could take even longer…

Related article:  New generation herbicide-tolerant soybeans, cotton gain USDA approval

In large part, the International Agency for Research on Cancer is to blame for the wait. The organization’s March 2015 report that found glyphosate to be a probable carcinogen has been dogging the regulatory efforts of policymakers around the world who have long said that glyphosate is safe in its approved uses. The report didn’t look at approved uses or exposure levels, but rather just if it’s possible for the chemical to cause cancer…

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis. Read full, original post: EPA’s glyphosate report now a spring thing (maybe)

News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend